Skip to main content
CYRAMZA 10 mg/mL solution by Eli Lilly and Company
CYRAMZA, 10 mg/mL, solution Drug class: Vascular Endothelial Growth Factor Receptor 2 Antagonist. Available on prescription only. Listed by Eli Lilly and Company.
Prescription only

CYRAMZA

ramucirumab

Listed by Eli Lilly and Company

Strength
10 mg/mL
Form
Solution
Route
Intravenous
Class
Vascular Endothelial Growth Factor Receptor 2…

What it contains

  • Ramucirumab 10 mg/mL

FDA record

Dosage form Solution
Route Intravenous
Drug class Vascular Endothelial Growth Factor Receptor 2 Antagonist
Approval route BLA — biologic licence
NDC code 0002-7669
FDA application BLA125477
RxNorm concept 1657775
Package sizes listed 1
Marketed since April 2014

Other products containing Ramucirumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

CYRAMZA

ramucirumab

Strength
10 mg/mL
Form
Solution
Class
Vascular Endothelial Growth Factor Rece…
Rx only

Eli Lilly and Company

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.